| RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES | |||||||||||||||
| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| Research and development expenses, as reported | $ | 268.6 | $ | 246.2 | $ | 537.6 | $ | 484.6 | |||||||
| Share-based compensation expense | (19.8 | ) | (26.1 | ) | (39.9 | ) | (52.7 | ) | |||||||
| Acquisition-related | (0.2 | ) | (0.2 | ) | (0.4 | ) | (0.4 | ) | |||||||
| Non-GAAP research and development expenses | $ | 248.6 | $ | 219.9 | $ | 497.3 | $ | 431.5 | |||||||
| Non-GAAP research and development expenses as a percentage of net sales | 12.0 | % | 13.3 | % | 12.3 | % | 13.4 | % | |||||||
Microchip Technology Announces Record Financial Results for Second Quarter of Fiscal Year 2023
 |  | More IC News
|
|
RELATED NEWS
